Simcere Pharmaceutical Co., Ltd
Clinical trials sponsored by Simcere Pharmaceutical Co., Ltd, explained in plain language.
-
New asthma drug aims to slash severe attacks in Hard-to-Treat patients
Disease control Recruiting nowThis study tests an experimental drug called SIM0718 for adults and teens (ages 12–75) with severe eosinophilic asthma that is not well controlled by current inhalers. Participants will receive either SIM0718 or a placebo alongside their usual medications. The main goal is to see…
Phase: PHASE3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New stroke pill aims to restore lost memory
Disease control Recruiting nowThis study tests a new tablet (edaravone dexborneol) to see if it can improve thinking and memory problems that happen after a stroke. About 226 adults who recently had a stroke and have some cognitive issues will take the tablet or a placebo for 24 weeks. The goal is to find out…
Phase: PHASE2 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New RSV pill for babies shows promise in major trial
Symptom relief Recruiting nowThis study tests an oral medicine called deurremidevir hydrobromide in infants and young children (1 month to 3 years old) with RSV infection. About 498 children will receive either the medicine or a placebo for 5 days. The goal is to see if the medicine helps relieve RSV symptom…
Phase: PHASE3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated May 17, 2026 06:46 UTC